Prof. Kui Liu | Breast Cancer | Best Researcher Award

Posted on by Pencis

Prof. Kui Liu | Breast Cancer | Best Researcher Award

Zibo Central Hospital | China

AUTHOR PROFILE

Scopus

KUI LIU, Ph.D. – PROFESSIONAL PROFILE

🎓 EARLY ACADEMIC PURSUITS

Kui Liu embarked on a robust academic journey in clinical and diagnostic sciences:

  • 2002-2005: Completed a degree in Clinical Laboratory Medicine from Linyi Medical College, China.
  • 2012-2015: Pursued a master’s degree in Clinical Laboratory Diagnostics at Jiangsu University, Zhenjiang, China.
  • 2016-2020: Earned a Ph.D. in Immunology from Southeast University, Nanjing, China, contributing significantly to the field with innovative research in immune responses and diagnostics.

💼 PROFESSIONAL ENDEAVORS

Kui Liu has accumulated extensive clinical and technical experience over nearly two decades:

  • 2020-Present: Associate Chief Technician at the Center of Translational Medicine, Zibo Central Hospital, where he plays a key role in integrating research with clinical applications.
  • 2015-2016: Worked as a Docimaster at the Blood Bank of the First Hospital of Zibo, focusing on blood storage and safety protocols.
  • 2008-2012: Served as a Docimaster at the same institution, ensuring high-quality diagnostic practices.
  • 2005-2008: Began his career as a Docimaster in the Laboratory Department, excelling in clinical diagnostics.

🧪 CONTRIBUTIONS AND RESEARCH FOCUS ON BREAST CANCER

Kui Liu’s research is centered on advancing the fields of immunology and clinical diagnostics, with a focus on:

  • The study of immune responses in various pathological conditions.
  • Development of innovative diagnostic tools and techniques.
  • Translation of scientific research into clinical solutions.

His work on immune mechanisms and diagnostic technologies has led to groundbreaking advancements in translational medicine.

💡 FUNDING AND RESEARCH IMPACT

Kui Liu has been a driving force behind several high-impact research projects, securing prestigious grants to fund cutting-edge studies:

  • Grant no. 81602330: Principal Investigator for the National Natural Science Foundation of China (2017-2019), focusing on immunological research.
  • Grant no. 81972002: Co-Investigator for the National Natural Science Foundation of China (2019-2022), contributing to collaborative advancements in the field.
  • Grant no. J18KA299: Co-Investigator in the Shandong Province Higher Educational Science and Technology Program (2019-2021).
  • Grant no. ZR2015PH056: Co-Investigator for the Natural Science Foundation of Shandong Province (2015-2016).
  • Grant no. CXLX13_689: Principal Investigator for the Innovation Project of Cultivating Graduates of Jiangsu Province (2013-2015).

🌍 IMPACT AND INFLUENCE

  • Innovator in Translational Medicine: Kui Liu has bridged the gap between laboratory research and clinical application, enhancing diagnostic capabilities in immunology.
  • National and Regional Contributions: Through leadership in provincial and national projects, he has elevated the standards of diagnostic medicine across China.
  • Collaboration and Mentorship: Actively fosters collaborations and guides aspiring researchers, contributing to the growth of the next generation of medical scientists.

📚 ACADEMIC CITES AND RECOGNITION

Kui Liu has received widespread recognition for his contributions, reflected in numerous citations and acknowledgments in scientific journals. His findings have influenced medical practices and inspired continued exploration in immunology.

🌟 LEGACY AND FUTURE CONTRIBUTIONS

Kui Liu’s career is a testament to his commitment to advancing medical science. His future endeavors include:

  • Leading innovative studies in immunological diagnostics.
  • Expanding the applications of translational medicine.
  • Continuing to inspire young researchers through mentorship and collaboration.

🌟CONCLUSION 

Dr. Kui Liu’s remarkable journey from foundational clinical studies to advanced immunological research exemplifies a career dedicated to innovation, excellence, and impact. His contributions to translational medicine and diagnostics have not only advanced scientific understanding but also improved clinical practices, particularly in immunology.

 

📊🔬NOTABLE PUBLICATION:
    1. Title: LncRNA DANCR-miR-758-3p-PAX6 Molecular Network Regulates Apoptosis and Autophagy of Breast Cancer Cells
      • Authors: Zhang, X.H., Li, B.F., Ding, J., Ma, F.X., Wu, X.Y.
      • Journal: Cancer Management and Research
      • Year: 2020
    1. Title: LncRNA PVT1 Regulates Gallbladder Cancer Progression through miR-30d-5p
      • Authors: Liu, K., Xu, Q.
      • Journal: Journal of Biological Regulators and Homeostatic Agents
      • Year: 2020
    1. Title: TIPE1 Inhibits Osteosarcoma Tumorigenesis and Progression by Regulating PRMT1 Mediated STAT3 Arginine Methylation
      • Authors: Yang, M., Zhang, Y., Liu, G., Liu, Q., Zhao, P.
      • Journal: Cell Death and Disease
      • Year: 2022
    1. Title: CircRNA hsa_circ_0008500 Acts as a miR-1301-3p Sponge to Promote Osteoblast Mineralization by Upregulating PADI4
      • Authors: Zhai, Q., Zhao, Y., Wang, L., Li, T., Wang, L.
      • Journal: Frontiers in Cell and Developmental Biology
      • Year: 2020
    1. Title: miR-369-3p Inhibits Tumorigenesis of Hepatocellular Carcinoma by Binding to PAX6
      • Authors: Xu, Q., Liu, K.
      • Journal: Journal of Biological Regulators and Homeostatic Agents
      • Year: 2020

Assoc. Prof. Dr. Feng Li | Tumor | Best Researcher Award

Posted on by Pencis

Assoc. Prof. Dr. Feng Li | Tumor | Best Researcher Award

Qufu Normal University | China

AUTHOR PROFILE

Scopus

Google Scholar

🏫 EARLY ACADEMIC PURSUITS

Assoc. Prof. Dr. Feng Li began their academic journey with a solid foundation in the life sciences, focusing on biology and computational biology during their undergraduate and graduate studies. They earned advanced degrees specializing in bioinformatics and oncology-related research, which positioned them at the intersection of biological data analysis and tumor research. Their early years were marked by exceptional performance, earning scholarships and accolades for academic excellence.

💼 PROFESSIONAL ENDEAVORS

Dr. Feng Li currently serves as an Associate Professor at Qufu Normal University in China. They have built a career that bridges teaching, research, and mentorship, shaping the next generation of scientists in the field of tumor biology and bioinformatics. They also collaborate with leading researchers and institutions, contributing to multidisciplinary projects and promoting innovation in their field.

🧬 CONTRIBUTIONS AND RESEARCH FOCUS ON TUMOR

Dr. Li’s primary research focus lies in tumor biology, particularly the application of bioinformatics to understand cancer mechanisms. Their work emphasizes:

  • Identifying biomarkers for cancer diagnostics and therapy.
  • Analyzing genomic and proteomic data to uncover tumor-related pathways.
  • Developing predictive models for patient outcomes using machine learning.

Their groundbreaking research has led to the publication of numerous peer-reviewed articles, advancing knowledge in cancer genomics and computational oncology.

🌍 IMPACT AND INFLUENCE

Through their research, Dr. Feng Li has significantly impacted the scientific community by:

  • Enhancing the understanding of cancer biology.
  • Introducing innovative bioinformatics tools for data analysis.
  • Influencing clinical practices with actionable insights from their studies.

Their work is frequently cited, reflecting their contributions to the broader academic discourse in oncology and bioinformatics.

📊 ACADEMIC CITES

Dr. Li’s publications have garnered widespread recognition, with a growing H-index reflecting their influence in the academic community. Their articles are cited by researchers worldwide, signifying the value and relevance of their findings.

🏅 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Feng Li’s legacy is marked by their dedication to advancing cancer research and mentoring young scientists. Looking ahead, their focus includes:

  • Expanding research in personalized cancer therapies.
  • Fostering collaborations between bioinformatics and clinical oncology.
  • Inspiring future generations through teaching and research initiatives.

🌟 OTHER IMPORTANT TOPICS

  • Teaching Excellence: Dr. Li is recognized for their engaging teaching methods, integrating real-world research into classroom learning.
  • Community Engagement: Actively participates in academic conferences and workshops, sharing their expertise and fostering knowledge exchange.
  • Interdisciplinary Approach: Their work exemplifies how bioinformatics and oncology can converge to solve complex medical challenges.

🌟CONCLUSION 

Assoc. Prof. Dr. Feng Li has emerged as a pivotal figure in the fields of tumor biology and bioinformatics, blending academic rigor with innovative research to tackle some of the most pressing challenges in oncology. Through their groundbreaking contributions, impactful teaching, and dedication to interdisciplinary collaboration, Dr. Li has left an indelible mark on the scientific community.

 

📊🔬NOTABLE PUBLICATION:
  • 1. SLGCN: Structure-enhanced line graph convolutional network for predicting drug–disease associations
    • Authors: Liu, B.-M., Gao, Y.-L., Li, F., Zheng, C.-H., Liu, J.-X.
    • Journal: Knowledge-Based Systems
    • Year: 2024

    2. A framework for scRNA-seq data clustering based on multi-view feature integration

    • Authors: Li, F., Liu, Y., Liu, J., Ge, D., Shang, J.
    • Journal: Biomedical Signal Processing and Control
    • Year: 2024

    3. KFDAE: CircRNA-Disease Associations Prediction Based on Kernel Fusion and Deep Auto-Encoder

    • Authors: Kang, W.-Y., Gao, Y.-L., Wang, Y., Li, F., Liu, J.-X.
    • Journal: IEEE Journal of Biomedical and Health Informatics
    • Year: 2024

    4. Multi-Affinity network integration based on multi-omics data for tumor stratification

    • Authors: Li, F., Gao, Y., Sun, Z., Shang, J., Liu, J.-X.
    • Journal: Biomedical Signal Processing and Control
    • Year: 2025

    5. A review: simulation tools for genome-wide interaction studies

    • Authors: Shang, J., Xu, A., Bi, M., Li, F., Liu, J.-X.
    • Journal: Briefings in Functional Genomics
    • Year: 2024

Prof. Hao Peng | RNA Epigenetic | Best Researcher Award

Posted on by Pencis

Prof. Hao Peng | RNA Epigenetic | Best Researcher Award

Guangdong Provincial People’s Hospital | China

AUTHOR PROFILE

Scopus

👩‍⚕️PROFESSOR YINGFEN YING: A DISTINGUISHED MEDICAL PROFESSIONAL🌍

📘 EARLY ACADEMIC PURSUITS

Prof. Hao Peng’s academic journey began with graduate studies at Sun Yat-sen University Cancer Center, where he laid the groundwork for his expertise in oncology. Following this, he undertook postdoctoral research at the First Affiliated Hospital of Sun Yat-sen University. This period marked his immersion in groundbreaking research, fostering a deep interest in RNA epigenetic modifications and their role in cancer biology.

💼 PROFESSIONAL ENDEAVORS

Currently a Professor and Surgical Oncologist at Guangdong Provincial People’s Hospital in China, Prof. Peng combines clinical practice with impactful research. His dual roles allow him to contribute both to patient care and the academic community, exemplifying the integration of clinical insights into scientific discovery.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON RNA EPIGENETIC

Prof. Peng’s primary research interests revolve around RNA epigenetic modifications in cancer, particularly:

  • tRNA m7G modification
  • 18S rRNA m6A modification
  • 28S rRNA m6A modification

He has elucidated how these modifications regulate mRNA translation and promote cancer progression. His findings have significantly enhanced the understanding of molecular mechanisms underlying oncogenesis.

🌍 IMPACT AND INFLUENCE

Prof. Peng has established himself as a thought leader in oncology, publishing several high-impact papers as the first and corresponding author in prestigious journals, including:

  • Nature Metabolism
  • Cell Reports
  • Cell Chemical Biology
  • Oncogene

These publications have contributed to advancing RNA epigenetics and its implications in cancer biology.

📊 ACADEMIC CITATIONS

With a growing citation impact, Prof. Peng’s research is widely referenced in the field, highlighting his influence on oncology research. His innovative work in RNA modifications has positioned him as a respected voice in his domain, shaping future studies in cancer therapeutics.

🔑 LEGACY AND FUTURE CONTRIBUTIONS

Prof. Peng has hosted multiple national research funds, emphasizing his role in advancing cancer research in China. His dedication to mentorship and collaboration ensures a lasting legacy in oncology. His ongoing research in RNA modifications holds promise for the development of novel therapeutic strategies, bridging the gap between molecular discoveries and clinical applications.

🏆 RECOGNITIONS AND LEADERSHIP

As a leader in the field, Prof. Peng continues to drive innovation in oncology. His contributions have earned him national recognition, solidifying his reputation as a pioneer in RNA epigenetics and its translational potential in cancer treatment.

🌟CONCLUSION 

Prof. Hao Peng’s exemplary career demonstrates the transformative impact of integrating molecular research with clinical practice. His pioneering work in RNA epigenetic modifications has reshaped the understanding of cancer progression and mRNA translation regulation. With a robust portfolio of influential publications, funded research projects, and a commitment to advancing oncology, Prof. Peng is not only contributing to the present scientific landscape but also paving the way for future breakthroughs in cancer therapeutics. His dedication to innovation, mentorship, and collaboration ensures a lasting legacy in the fight against cancer, inspiring both his peers and the next generation of researchers.

 

📊🔬NOTABLE PUBLICATION:
  • N7-methylguanosine tRNA modification promotes esophageal squamous cell carcinoma tumorigenesis via the RPTOR/ULK1/autophagy axis
    • Authors: Han, H.; Yang, C.; Ma, J.; …; Choe, J.; Lin, S.
    • Journal: Nature Communications
    • Year: 2022

 

  • N6-methyladenosine (m6A) in 18S rRNA promotes fatty acid metabolism and oncogenic transformation
    • Authors: Peng, H.; Chen, B.; Wei, W.; …; Kuang, M.; Lin, S.
    • Journal: Nature Metabolism
    • Year: 2022

 

  • N7-methylguanosine tRNA modification promotes tumorigenesis and chemoresistance through WNT/β-catenin pathway in nasopharyngeal carcinoma
    • Authors: Chen, B.; Jiang, W.; Huang, Y.; …; Wu, L.; Peng, H.
    • Journal: Oncogene
    • Year: 2022

 

  • N6-methyladenosine modification in 18S rRNA promotes tumorigenesis and chemoresistance via HSF4b/HSP90B1/mutant p53 axis
    • Authors: Chen, B.; Huang, Y.; He, S.; …; Wu, L.; Peng, H.
    • Journal: Cell Chemical Biology
    • Year: 2023

 

  • Nomogram-aided individual induction chemotherapy regimen selection in advanced nasopharyngeal carcinoma
    • Authors: Peng, H.; Chen, L.; Mao, Y.-P.; Tian, L.; Liu, L.-Z.
    • Journal: Oral Oncology
    • Year: 2021

Prof. Yingfen Ying | Tumors | Women Researcher Award

Posted on by Pencis

Prof. Yingfen Ying | Tumors | Women Researcher Award

Wenzhou Medical University | China

AUTHOR PROFILE

Scopus

PROFESSOR YINGFEN YING: A DISTINGUISHED MEDICAL PROFESSIONAL 👩‍⚕️🌍

EARLY ACADEMIC PURSUITS 🎓✨

Professor Yingfen Ying embarked on her academic journey with a strong focus on medical sciences, demonstrating an early aptitude for research and clinical excellence. Her academic foundation was fortified through rigorous education at Wenzhou Medical University, where she gained critical knowledge and skills that paved the way for her distinguished career. She further enriched her expertise as a visiting scholar at the University of British Columbia in Canada, a testament to her global academic vision.

PROFESSIONAL ENDEAVORS 💼🏥

Professor Ying has made significant strides as an Associate Chief Physician and master’s supervisor at Wenzhou Medical University. Her roles extend to various esteemed positions, including:

  • Member of the Obstetrics and Gynecology Rehabilitation Committee, Chinese Rehabilitation Medicine Association.
  • Vice Chairwoman of the Youth Committee, Reproductive Medicine Branch, Zhejiang Society of Traditional Chinese and Western Medicine.
  • Member of the Obstetrics and Gynecology Branch, Zhejiang Society of Translational Medicine.
    She is also affiliated with prominent international organizations, such as the American Society of Reproductive Medicine and the European Society of Human Reproduction and Embryology.

CONTRIBUTIONS AND RESEARCH FOCUS 🔬📚

Professor Ying’s primary research interests center on the mechanistic study of environmental endocrine disruptors and reproductive endocrine diseases. Her investigations delve into the interplay between environmental factors and hormonal imbalances, significantly advancing our understanding of infertility diseases. She has led multiple national and international research projects, including those funded by the National Natural Science Foundation of China.

IMPACT AND INFLUENCE 🌟🌏

Professor Ying’s work has had far-reaching impacts in the field of reproductive medicine. She has authored nearly 30 SCI-indexed papers, contributing valuable insights and advancements to the global medical community. Her research continues to influence clinical practices and guide innovative therapeutic approaches for infertility.

ACADEMIC CITES AND PATENT ACHIEVEMENTS 📜🔑

Professor Ying’s extensive research portfolio has garnered numerous citations in high-impact journals. Additionally, she holds a European patent, exemplifying her contributions to advancing medical technology and treatment methodologies on a global scale.

LEGACY AND FUTURE CONTRIBUTIONS 🌟🚀

As a trailblazer in reproductive medicine, Professor Yingfen Ying’s legacy is defined by her commitment to advancing medical science, mentoring future generations, and improving patient outcomes. Her ongoing projects and international collaborations promise continued breakthroughs, ensuring her work remains at the forefront of reproductive health and endocrine research.

ADDITIONAL HIGHLIGHTS 🌐📖

  • Active member of youth committees in Zhejiang’s medical and scientific communities, fostering innovation and development among emerging scholars.
  • Her dedication to integrating traditional Chinese and Western medicine highlights a holistic approach to patient care and research.
  • International affiliations reflect her commitment to global medical advancements, strengthening ties between diverse medical communities.

CONCLUSION 🌟🏆

Professor Yingfen Ying exemplifies excellence in the fields of reproductive medicine and endocrine research. Her dedication to uncovering the mechanisms of infertility diseases and environmental endocrine disruptors has advanced both science and clinical practice. Through her leadership roles, impactful publications, and international collaborations, she has established herself as a global authority and advocate for holistic and innovative approaches to healthcare.

 

📊🔬NOTABLE PUBLICATION:
  • Title: Halogen atoms determine the inhibitory potency of halogenated bisphenol A derivatives on human and rat placental 11β-hydroxysteroid dehydrogenase 2
    Authors: Shi, L., Zhang, B., Ying, Y., Ge, R.-S., Liu, Y.
    Journal: Food and Chemical Toxicology
    Year: 2023

 

  • Title: Inhibitory effects of parabens on human and rat 17β-hydroxysteroid dehydrogenase 1: Mechanisms of action and impact on hormone synthesis
    Authors: Chen, Z., Gong, C., Tang, Y., Ge, R.-S., Ying, Y.
    Journal: Toxicology
    Year: 2024

 

  • Title: Per- and polyfluoroalkyl substances inhibit human and rat 17β-hydroxysteroid dehydrogenase 1: Quantitative structure-activity relationship and molecular docking analysis
    Authors: Wen, C., Chen, H., Tang, Y., Chen, C., Chen, S.
    Journal: Ecotoxicology and Environmental Safety
    Year: 2024

 

  • Title: Leydig cell development in pubertal male rats is blocked by perfluorotetradecanoic acid through decreasing AMPK-mTOR-autophagy pathway
    Authors: Tang, Y., Shi, L., Wang, S., Ge, R.-S., Ying, Y.
    Journal: Toxicology Letters
    Year: 2023

 

  • Title: Structure-activity relationship and in silico docking analysis of dicarboximide fungicides on 17β-hydroxysteroid dehydrogenase 1 of human, rat, and pig
    Authors: Chen, H., Chen, S., Tang, Y., Ge, R.-S., Duan, P.
    Journal: Ecotoxicology and Environmental Safety
    Year: 2025

Dr. Yaqin Wu | Carcinoma | Women Researcher Award

Posted on by Pencis

Dr. Yaqin Wu | Carcinoma | Women Researcher Award

Hunan provincial people’s hospital | China

AUTHOR PROFILE

Scopus

🌟Wu Yaqin 

🏥CURRENT ROLES AND AFFILIATIONS 

  • Current Position: Organizational Committee Member, Graduate Student Party Branch
  • Graduate Institution: Hunan Provincial People’s Hospital (Hunan Normal University First Affiliated Hospital), Breast and Thyroid Surgery, Master’s Supervisor: Professor Zhang Chaojie
  • Undergraduate Institution: Hunan Normal University Medical School, Clinical Medicine (2014.9–2019.6)

📚EARLY ACADEMIC PURSUITS 

Wu Yaqin began her academic journey at Hunan Normal University Medical School, excelling in Clinical Medicine. Her undergraduate years were marked by stellar academic performance, with scholarships awarded every year, including National Scholarship and National Inspirational Scholarship.

🔬PROFESSIONAL ENDEAVORS 

Currently pursuing a Master’s degree in Surgery (Breast and Thyroid Surgery) at Hunan Provincial People’s Hospital, Wu has honed her clinical and research skills. She has gained recognition for:

  1. Outstanding clinical rotation performance.
  2. Active participation in surgeries, assisting in level 3 and 4 operations.
  3. Representing her hospital in Clinical Skills Competitions.

🧪CONTRIBUTIONS AND RESEARCH FOCUS 

Wu Yaqin has a strong foundation in research and innovation, focusing on:

  • Scientific Techniques: Proficiency in WB, PCR, single-cell sequencing, metabolomics, and other experimental skills.
  • Data Analysis: Skilled in SPSS, bioinformatics, and advanced statistical analysis.
  • Publications:
    • 2 SCI papers as the first and corresponding author (Cumulative Impact Factor: 5.143).
    • 2 core journal publications in China.
  • Research Projects:
    • Contributed to two provincial-level projects and two horizontal projects as the lead researcher (under mentor guidance).

🌟IMPACT AND INFLUENCE 

Wu’s contributions extend beyond academia:

  • Regularly earns recognition as an Outstanding Party Member, Student, and Graduate.
  • Actively involved in expert consensus compilation, adding to professional guidelines.
  • Participates in large-scale event organization with exceptional planning and execution skills.

PERSONAL SKILLS AND INTERESTS 🎙️

  • Language Proficiency:
    • Passed CET-4 and CET-6.
    • Achieved Grade 2-A in the National Mandarin Test.
  • Technical Skills:
    • Proficient in basic and advanced experimental techniques.
    • Skilled in computer applications (provincial-level certification).
  • Special Interests: Broadcasting, hosting, debate, and recitation.

RECOGNITION AND HONORS 🏅

During Master’s Program:

  • Authored high-impact research papers.
  • Contributed to prestigious projects and received multiple awards for academic excellence.

During Undergraduate Program:

  • Awarded numerous scholarships and honors.
  • Served in various leadership roles:
    • Vice Minister, Learning Department of the Student Union.
    • Captain, Debate Team.
    • Psychological Committee Member, Class Representative.

LEGACY AND FUTURE CONTRIBUTIONS 🌐

Wu Yaqin’s dedication to clinical excellence, innovative research, and effective communication positions her as a rising star in medical sciences. She is committed to:

  1. Advancing clinical practice and surgical expertise.
  2. Expanding her impact through cutting-edge research and mentorship roles.
  3. Building a legacy of leadership and service within the medical community.

 

📊🔬NOTABLE PUBLICATION:
  • 1. LncRNA SNHG5 promotes the glycolysis and proliferation of breast cancer cell through regulating BACH1 via targeting miR-299
    • Authors: Huang, S.-L., Huang, Z.-C., Zhang, C.-J., Wu, Y.-Q., Fan, P.-Z.
    • Journal: Breast Cancer
    • Year: 2022

    2. The expression and meaning of CD68, CD163, CD57, and IgG4 in granulomatous lobular mastitis

    • Authors: Kong, C., Zhang, C., Wu, Y., He, J., Fan, P.
    • Journal: Gland Surgery
    • Year: 2020

    3. miRNA-195-5p/PSAT1 feedback loop in human triple-negative breast cancer cells

    • Authors: Wang, H., Fang, Q., You, S., Wu, Y., Zhang, C.
    • Journal: Genes and Genomics
    • Year: 2023

    4. Value of dissection of lymph nodes posterior to the right recurrent laryngeal nerve in patients with cN0 papillary thyroid carcinoma

    • Authors: Xiao, X., Wu, Y., Zou, L., Chen, Y., Zhang, C.
    • Journal: Gland Surgery
    • Year: 2022

    5. A clinical observation of stage I implant breast reconstruction for mass-like granulomatous lobular mastitis

    • Authors: Zhang, C., Wu, Y., Wang, H., Li, Q., Fan, P.
    • Journal: Gland Surgery
    • Year: 2021

Prof. Maoyi Xu | Thoracic Neoplasms | Best Researcher Award

Posted on by Pencis

Prof. Maoyi Xu | Thoracic Neoplasms | Best Researcher Award

The Affiliated Hospital of Jiaxing University | China

AUTHOR PROFILE

Scopus

🏫 EARLY ACADEMIC PURSUITS

Maoyi Xu began his academic journey with a Bachelor of Medicine in Clinical Medicine at Jiaxing University (2009–2014). During these formative years, Xu developed a strong foundation in medical sciences and clinical applications, showcasing a keen interest in oncology. This passion led him to pursue advanced education, obtaining a Master of Medicine in Oncology from Dalian Medical University, China, in 2017. His graduate studies were characterized by rigorous research and hands-on training, laying the groundwork for his future career in oncology.

💼 PROFESSIONAL ENDEAVORS

Maoyi Xu’s professional career began with a pivotal role at the Department of Radiotherapy Oncology, Zhuji People’s Hospital of Zhejiang Province (2017–2019), affiliated with Wenzhou Medical University. Here, he honed his skills in radiotherapy and gained invaluable experience treating cancer patients.
In 2019, Xu transitioned to the Department of Oncology at the First Affiliated Hospital of Jiaxing University, where he continues to work. His role involves comprehensive patient care, cutting-edge research, and contributions to the hospital’s oncology department’s growth.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON THORACIC NEOPLASMS

Xu has focused his research on innovative cancer treatment strategies, particularly in radiotherapy and targeted oncology treatments. He is committed to improving patient outcomes by integrating the latest advancements in oncology into clinical practice. Xu’s research bridges the gap between theory and application, enhancing therapeutic methodologies to benefit patients.

🌟 IMPACT AND INFLUENCE

Through his work, Xu has positively influenced oncology practices within Zhejiang Province and beyond. His contributions have led to advancements in radiotherapy techniques and improved patient care protocols. Xu is also a mentor to young professionals, fostering a culture of learning and collaboration.

📊 ACADEMIC CITATIONS

Although Xu’s academic citations are in development, his publications have started to gain recognition in medical circles. His research papers focus on innovative radiotherapy approaches and patient-centered care strategies. These contributions are adding value to the field of oncology.

🏅 LEGACY AND FUTURE CONTRIBUTIONS

Maoyi Xu is poised to leave a lasting legacy as a dedicated oncologist and researcher. He envisions a future where his contributions will significantly impact cancer treatment practices and policies, particularly in China. Xu aims to pioneer new research initiatives, foster interdisciplinary collaboration, and improve cancer care at both the local and global levels.

OTHER IMPORTANT TOPICS

🌐 COMMUNITY ENGAGEMENT

Xu actively participates in health awareness programs, aiming to educate the public about early cancer detection and prevention.

📚 CONTINUOUS LEARNING

A proponent of lifelong learning, Xu frequently attends conferences and workshops, staying updated on the latest developments in oncology.

🧬 INNOVATIVE PRACTICES

Xu is exploring personalized medicine and genetic research in oncology, positioning himself at the forefront of emerging trends.

📝 CONCLUSION

Maoyi Xu’s journey from an aspiring medical student to a dedicated oncologist and researcher exemplifies a commitment to excellence and innovation in the field of oncology. His academic pursuits laid a solid foundation for his professional growth, while his clinical and research contributions continue to impact cancer treatment and patient care.

 

📊🔬NOTABLE PUBLICATION:
  • The combination of decitabine and aspirin inhibits tumor growth and metastasis in non-small cell lung cancer
    • Authors: Xu, M., Song, B., Yang, X., Li, N.
    • Journal: Journal of International Medical Research
    • Year: 2022

 

  • Exosomal miR-122-3p represses the growth and metastasis of MCF-7/ADR cells by targeting GRK4-mediated activation of the Wnt/β-catenin pathway
    • Authors: Song, B., Hou, G., Xu, M., Chen, M.
    • Journal: Cellular Signalling
    • Year: 2024

 

  • Zoledronic acid inhibits the bone metastasis of breast cancer by repressing exosome-loaded DKK1
    • Authors: Song, B.B., Xu, M.Y., Xu, X.F., Li, X., Chen, M.
    • Journal: Bangladesh Journal of Pharmacology
    • Year: 2022

 

  • Association between the Khorana risk score and all-cause mortality in Japanese patients with gastric and colorectal cancer: A retrospective cohort study
    • Authors: Zhang, Y.-F., Wang, G.-D., Huang, M.-G., Si, J., Xu, M.-Y.
    • Journal: World Journal of Gastrointestinal Oncology
    • Year: 2023

 

  • β-elemene inhibits radiation and hypoxia-induced macrophages infiltration via Prx-1/NF-κB/HIF-1α signaling pathway
    • Authors: Yu, X., Li, Z., Zhang, Y., Zou, K., Zou, L.
    • Journal: OncoTargets and Therapy
    • Year: 2019

Mr. Ji Huang | Dosimetric Research | Best Researcher Award

Posted on by Pencis

Mr. Ji Huang | Dosimetric Research | Best Researcher Award

National Institute of Metrology | China

Author Profile

Scopus

🌟 Biography of Huang Ji 🌟

🧪 Full Name:

Huang Ji

🏛️ Designation:

Research Professor

🏢 Institution/Organization:

National Institute of Metrology, China (NIM)

🌐 Academic and Professional Background

Huang Ji is a distinguished researcher in ionizing radiation metrology with a focus on FLASH radiotherapy, small-field dosimetry standards, and metrology systems. He has contributed to the establishment of two national standards and drafted two technical specifications in radiotherapy metrology. Huang serves as the Deputy Secretary-General of the Ionizing Radiation Committee of the China Society for Measurement and is an active member of the Medical Physics Division of the Chinese Nuclear Society.

🔬 Research and Innovations

  • 🎯 Completed/Ongoing Research Projects: Led several national-level projects, including the Young Scientists Program of the National Key R&D Program and projects funded by the National Natural Science Foundation of China.
  • 📈 Citation Index: H-Index of 11.
  • 🔗 Consultancy/Industry Projects: Worked on projects under the National Key R&D Program and National Natural Science Foundation of China.
  • 📚 Books Published (ISBN): None.
  • 🔒 Patents Published/Under Process: Over 10 invention patents.
  • 📝 Journals Published: More than 20 SCI-indexed papers.
  • 🖋️ Editorial Appointments: Editorial member of Nuclear Science and Technology.

🤝 Collaborations

Worked with prominent institutions such as:

  • Tsinghua University
  • Beijing Cancer Hospital
  • Peking University
  • China Academy of Engineering Physics

🌟 Professional Memberships

  • Deputy Secretary-General, Ionizing Radiation Committee, China Society for Measurement
  • Member, Medical Physics Division, Chinese Nuclear Society

🔍 Areas of Research

Huang Ji’s research focuses on:

  • FLASH radiotherapy
  • Small-field dosimetry standards
  • Advanced metrology systems

🚀 Key Contributions

Huang Ji developed a comprehensive Monte Carlo model to analyze dosimetry errors and introduced an innovative FFF output correction factor. This breakthrough addresses dosimetry errors across various ionization chambers and electron angle conditions, significantly advancing precision in FFF radiotherapy.

🌟 Impact: His work enhances accuracy in radiotherapy, contributing to improved patient outcomes and advancing metrology science.

📊🔬NOTABLE PUBLICATION:
  • Uniformity Control of Laser-Induced Periodic Surface Structures
    • Authors: Huang, J.; Liu, Y.; Jin, S.; Wang, K.; Qiu, R.
    • Journal: Frontiers in Physics
    • Year: 2022

 

  • Single-Pixel-Adjustable Structural Color Fabricated Using a Spatially Modulated Femtosecond Laser
    • Authors: Liu, Y.; Jiang, L.; Li, X.; Ye, Y.; Wang, Z.
    • Journal: ACS Applied Materials and Interfaces
    • Year: 2023

 

  • Efficient Fabrication of Infrared Antireflective Microstructures on a Curved Diamond-ZnS Composite Surface by Using Femtosecond Bessel-like Beams
    • Authors: Mengnan, W.U.; Jiang, L.; Taoyong, L.I.; Zhang, X.; Li, X.
    • Journal: Optics Express
    • Year: 2023

 

  • Development and Application of Absorbed Dose Primary Standard for 60^{60}Co and High-Energy Photon Beams Using Water Calorimetry
    • Authors: Wang, Z.; Wang, K.; Jin, S.; Qi, Y.; Zhang, J.
    • Journal: Metrologia
    • Year: 2023

 

  • Alternate Morphology Evolution of Bulge Structures on Thin Gold Films Induced by Internal Stress Distribution Adjusted by Femtosecond Laser Double-Pulse
    • Authors: Gao, S.; Li, X.; Lian, Y.; Fu, Z.; Huang, J.
    • Journal: Optics and Laser Technology
    • Year: 2022

Prof. Xinyan Zhao | Liver Injury | Best Researcher Award

Posted on by Pencis

Prof. Xinyan Zhao | Liver Injury | Best Researcher Award

Beijing Friendship Hospital, Capital Medical University | China

Author Profile

Scopus

Google Scholar

Biography of Xin Yan Zhao, M.D., Ph.D. 🌟🩺

Professor of Medicine | Head of Liver Research Center | Expert in Hepatology

Dr. Xin Yan Zhao is a distinguished Professor of Medicine and the Head of the Liver Research Center at Beijing Friendship Hospital, Capital Medical University, Beijing, China. She is also affiliated with the National Clinical Research Center for Digestive Disease, where she leads groundbreaking research in hepatology and liver transplantation pathology.

🎓 Education

  • M.D. (1995–2000)
    Clinical Medicine, Capital Medical University, Beijing, China
  • M.S. (2000–2003)
    Internal Medicine, Capital Medical University, Beijing, China
  • Ph.D. (2005–2008)
    Hepatology, Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China

👩‍⚕️ Professional Experience

  • Head of Liver Research Center (2022–Present)
    Beijing Friendship Hospital, Capital Medical University
  • Hepatologist & Clinical Liver Pathologist (2016–2022)
    Beijing Friendship Hospital, Capital Medical University
  • Visiting Scholar (2015–2016)
    Department of Liver and Transplant Pathology, University of Pittsburgh Medical Center, USA
  • Associate Professor (2014–2015)
    Beijing Friendship Hospital, Capital Medical University
  • Attending Doctor, Department of Hepatology (2009–2014)
    Beijing Friendship Hospital, Capital Medical University
  • Chief Resident of Internal Medicine (2008)
    Beijing Friendship Hospital, Capital Medical University
  • Resident of Internal Medicine (2003–2007)
    Beijing Friendship Hospital, Capital Medical University

🏆 Awards and Honors

  • 2006: Excellent Paper Presentation Award, Chinese Society of Hepatology
  • 2008, 2010, 2013: Excellence in Teaching Award, Beijing Friendship Hospital
  • 2010: Award for Teaching Presentation and Skills in English, Capital Medical University
  • 2014: Excellent Young Investigator Award, APASL College, Beijing
  • 2018: Excellent Paper Presentation Award, Beijing Digestive Disease Weekend

🌐 Roles in Professional Societies

  1. Chairman (2024–2025), Pathology Committee, International Liver Transplantation Society 🌍
  2. Committee Member, Autoimmune Hepatitis Cooperation Group, Chinese Society of Hepatology
  3. Committee Member, Transplantation Pathology, Chinese Medical Doctor Association
  4. Committee Member, Digestive Pathology Cooperation Group, Chinese Society of Digestive Diseases

🌏 CONCLUSION

Dr. Xin Yan Zhao exemplifies excellence in medicine, research, and education. As a globally recognized leader in hepatology and liver transplantation pathology, she continues to drive innovation and collaboration in the field. Her dedication to advancing medical knowledge, training the next generation of physicians, and contributing to professional societies underscores her significant impact on liver research and clinical practice worldwide. 🌟🩺

📊🔬NOTABLE PUBLICATION:
  • Peridroplet mitochondria are associated with the severity of MASLD and the prevention of MASLD by diethyldithiocarbamate
    • Authors: Sun, X.; Yu, Q.; Qi, Y.; Cong, M.; Liu, T.
    • Journal: Journal of Lipid Research
    • Year: 2024

 

  • Autoimmune hepatitis with confluent necrosis indicates severe liver injury but responds well to standard immunosuppressive therapy
    • Authors: Sun, X.; Su, Y.; Wee, A.; Zhao, X.; Jia, J.
    • Journal: Histology and Histopathology
    • Year: 2024

 

  • Prevalence and clinical profiles of primary sclerosing cholangitis in China: Data from electronic medical records and systematic literature retrieval
    • Authors: Xu, X.; Meng, T.; Shi, L.; Jia, J.; Kong, Y.
    • Journal: Journal of Autoimmunity
    • Year: 2024

 

  • Multiscale X-ray phase-contrast CT uncovers adaptive changes and compensatory mechanisms of circulatory pathways during acute liver injury
    • Authors: Zhao, Y.; Lv, W.; He, Y.; Hu, C.; Jian, J.
    • Journal: Communications Biology
    • Year: 2024

 

  • Multiple Low-Level Viraemia Suggest Hindered Liver Fibrosis Regression in Chronic Hepatitis B Patients During Antiviral Therapy
    • Authors: Lu, Z.; Sun, Y.-M.; Chen, S.; Zhao, X.; You, H.
    • Journal: Journal of Viral Hepatitis
    • Year: 2024

Dr. Ohidul Alam | Oncology Case Reports | Best Researcher Award

Posted on by Pencis

Dr. Ohidul Alam | Oncology Case Reports | Best Researcher Award

Jiangsu University | China

Author Profile

Scopus

Google Scholar

🌍 Dr. Ohidul Alam: Postdoctoral Research Fellow and Environmental Innovator 🌱

💧Current Position

  • Postdoctoral Research Fellow, Institute of Environment and Ecology, School of the Environment and Safety Engineering, Jiangsu University

♻️Research Focus

Dr. Ohidul Alam is dedicated to advancing environmental sustainability and ecological safety. His primary research interests include:

  • 🌊 Coastal Environment and Wetlands: Investigating microplastics as vectors for antibiotic resistance genes (ARGs) and heavy metals.
  • ♻️ Hazardous Waste Management: Treatment and recycling of waste and heavy metals.
  • 💧 Wastewater Treatment and Pollution Control: Developing advanced environmental materials like adsorbents and composites for energy storage and purification.
  • 🧬 Antibiotic Resistance Genes: Exploring ARG mechanisms in ecological systems.

🎓Education 

  • PhD in Environmental Engineering, East China University of Science and Technology, Shanghai, China (2016–2021)
  • MEng in Environmental Engineering, UNEP-Tongji Institute of Environment for Sustainable Development, Tongji University, Shanghai, China (2014–2016)
  • MS in Environmental Science, Institute of Forestry and Environmental Sciences, University of Chittagong, Bangladesh (2010–2011)

🛠Career Snapshot 

  • Postdoctoral Research (2023–Present): Investigating microplastics as vehicles for ARGs and toxic heavy metals in coastal wetlands, assessing ecological and health risks.
  • Environmental Officer (2022–2023): Sustainable Enterprise Project (SEP), Integrated Development Foundation (IDF).
  • Research Associate and Assistant: Contributed to seven major academic and socio-environmental projects.

🖋Publications and Contributions 

  • Published 15 SCI-indexed journal papers, 9 international open-access journal articles, and 13 international conference papers.
  • Authored 3 national journal articles and 3 technical/working papers.
  • Supported colleagues in research, thesis writing, and scientific publications.

🏆Recognition and Awards 

  • Chinese Scholarship Council (CSC) and Marine Scholarship of China (MSC), 2014
  • Tongji University President Scholarship (2nd Prize), 2015, for academic excellence.

🤝Professional Memberships 

  • International Waste Working Group (IWWG)
  • Human Development Foundation (HDF)

🧾Reviewer Roles 

  • Journal of Environmental Management
  • Environmental Research
  • Environment, Development and Sustainability
  • Water Science and Technology

📚Training and Skills Development 

  • Completed advanced training on the Leaching Environmental Assessment Framework (LEAF) for waste treatment and beneficial reuse.

Dr. Alam’s interdisciplinary approach bridges the gap between environmental engineering, sustainable development, and ecological safety. His work continues to inspire progress toward a cleaner, safer world. 🌍✨

🌏 CONCLUSION

Dr. Ohidul Alam exemplifies dedication to environmental sustainability through his groundbreaking research on hazardous waste management, pollution control, and ecological risks posed by microplastics. His extensive academic achievements, impactful publications, and hands-on contributions to global environmental projects highlight his expertise and commitment to creating sustainable solutions for pressing environmental challenges. As a scholar, innovator, and mentor, Dr. Alam continues to pave the way for a cleaner, safer, and more sustainable future. 🌱🌍

📊🔬NOTABLE PUBLICATION:
  • Title: An in-depth review on municipal solid waste management, treatment, and disposal in Bangladesh
    • Authors: Alam, O.; Qiao, X.
    • Journal: Sustainable Cities and Society
    • Year: 2020

 

  • Title: A preliminary life cycle assessment on healthcare waste management in Chittagong City, Bangladesh
    • Authors: Alam, O.; Mosharraf, A.
    • Journal: International Journal of Environmental Science and Technology
    • Year: 2020

 

  • Title: Influences of chemically controlled Ca-bearing minerals in chitosan on Pb²⁺ removal efficiency
    • Authors: Alam, O.; Qiao, X.
    • Journal: Journal of Environmental Health Science and Engineering
    • Year: 2020

 

  • Title: The effect of Ca-bearing contents in chitosan on Pb²⁺, Cd²⁺, and Cu²⁺ adsorption and its adsorption mechanism
    • Authors: Alam, O.; Qiao, X.; Nath, T.K.
    • Journal: Journal of Environmental Health Science and Engineering
    • Year: 2020

 

  • Title: Remediation of heavy metals polluted soil environment: A critical review on biological approaches
    • Authors: Zheng, X.; Lin, H.; Du, D.; Jiang, S.; Li, J.
    • Journal: Ecotoxicology and Environmental Safety
    • Year: 2024

Prof. Dehua Li | Peri-implantitis | Best Researcher Award

Posted on by Pencis

Prof. Dehua Li | Peri-implantitis | Best Researcher Award

Air Force Medical University | China

Author Profile

Scopus

🌟Biography of Dehua, Li 🦷🧬

Dr. Dehua Li is a researcher at the State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Air Force Medical University, Xi’an, China. His work bridges cutting-edge nanotechnology with transformative solutions in biomedicine, particularly for dental health applications.

🔬 Research Focus

  • Development and application of nanotechnology in biomedical fields
  • Innovative strategies for biofilm decontamination and peri-implantitis management in dental implantology
  • Design of pH-responsive drug delivery systems for precision medicine
  • Interdisciplinary approaches to integrating nanomaterial technologies into clinical solutions

💡 Key Contributions

  • Designed D-arginine-loaded pH-responsive mesoporous silica nanoparticles (Dar@MSN-COS) to target biofilms on dental implants effectively.
  • Spearheaded in vitro and in vivo studies demonstrating the biocompatibility and therapeutic potential of Dar@MSN-COS in treating peri-implantitis.
  • Advanced research into the synergistic effects of nanotechnology and mechanical decontamination techniques, such as water jet therapy, for improving implant reosseointegration.

🔧 Core Skills

  • Nanoparticle synthesis and functionalization
  • Advanced microscopy techniques, including SEM and CLSM
  • Expertise in drug release profiling, cytotoxicity assays, and biofilm characterization
  • Proficiency in analytical tools like FTIR, DLS, and statistical software (SPSS, GraphPad Prism)

🏆 Awards and Grants

  • Recipient of the Foundation of National Clinical Research Center for Oral Diseases (Grant NO: LCC202202)

With his innovative approaches and multidisciplinary expertise, Dr. Dehua Li is contributing to the advancement of precision medicine and oral health, fostering solutions that promise better outcomes in implantology and beyond.

🌏 CONCLUSION

In conclusion, Dr. Dehua Li is at the forefront of advancing dental health and precision medicine through his expertise in nanotechnology and biomaterials science. His innovative work in developing pH-responsive drug delivery systems and synergistic decontamination methods addresses critical challenges in peri-implantitis management and dental implantology.

📊🔬NOTABLE PUBLICATION:
  • Additive Manufacturing Technologies in the Oral Implant Clinic: A Review of Current Applications and Progress
    • Authors: Huang, S., Wei, H., Li, D.
    • Journal: Frontiers in Bioengineering and Biotechnology
    • Year: 2023

 

  • Asperuloside Prevents Peri-Implantitis via Suppression of NF-κB and ERK1/2 on Rats
    • Authors: Wang, X., Chen, X., Zhang, Z., Wei, H., Li, D.
    • Journal: Pharmaceuticals
    • Year: 2022

 

  • A Novel Technique for Implant-Supported Fixed Complete Rehabilitation Based on a Dynamic Virtual Patient
    • Authors: Wang, J., Wu, Y.-L., Ma, J., Wu, F., Li, D.-H.
    • Journal: Journal of Dentistry
    • Year: 2023

 

  • Surgical Principles and the Decision-Making for Peri-Implant Keratinized Mucosa Augmentation
    • Authors: Li, D.
    • Journal: Chinese Journal of Stomatology
    • Year: 2023

 

  • Influences of Standardized Clinical Probing on Peri-Implant Soft Tissue Seal in a Situation of Peri-Implant Mucositis: A Histomorphometric Study in Dogs
    • Authors: Cai, R., Liu, Y., Wang, X., Lei, J., Li, D.
    • Journal: Journal of Periodontology
    • Year: 2024